Biotecnología

Biotecnología

VantAI, BMS Partner to Accelerate Molecular Glue Drug Discovery
22/02/2024 - Will leverage VantAI's geometric deep learning capabilities with Bristol Myers Squibb’s expertise in targeted protein degradation.
Firefly Bio Debuts with $94M Series A Funding Round
22/02/2024 - Funding will support its novel platform for treating cancer by merging antibody-drug conjugates with protein degraders.
Biognosys Opens New Proteomics Facility in MA
01/02/2024 - Expansion facilitates access to select proteomics contract research organization (CRO) services for the company’s US biopharma customers.
Entos Pharma Launches GMP Clinical Mfg. Facility in Carlsbad
30/01/2024 - Will manufacture genetic medicines based on Entos Fusogenix PLV platform, including recombinant protein, mRNA, and plasmid DNA.
Almac Sciences Extends selectAZyme Offering
25/01/2024 - Kit contains focussed library of 10 double stranded RNA Ligase enzymes selected from an extended RNAL enzyme panel.
GSK Licenses Elegen’s Cell-Free DNA Mfg. Technology
25/01/2024 - Has potential to enable a seamless transition from discovery to clinical scale-up under GMP.
AGC Biologics to Open New Manufacturing Site in Japan
19/01/2024 - Will offer preclinical through commercial services for mammalian-based protein biologics, cell therapies, and messenger RNA.
CordenPharma, pHLIP Partner on RNA & Gene Therapies
19/01/2024 - Aims to develop and manufacture small molecule drug payloads directly conjugated with (pHLIP) peptides.
Abzena Launches AbZelect Platforms for Cell Line Development
19/01/2024 - Designed to enable the rapid generation and selection of high-yielding mammalian CHO cell lines for therapeutic protein and recombinant vaccine production.
Eurofins Alphora Completes Pilot Scale mAbs Development Facility
19/01/2024 - 3,300 sq.-ft. facility dedicated to development and scaling of mAbs and other mammalian-based therapeutic proteins.
Remix, Roche Enter Small Molecule RNA Processing Pact
04/01/2024 - To develop small molecules that modulate RNA processing using Remix's REMaster drug discovery platform.
Healis, CKD Bio Ink Supply Deal to Develop Neuromodulator Protein
03/01/2024 - Aims to develop CKDB-501 for major depressive disorder and post-traumatic stress disorder.
CARVYKTI
26/12/2023 - For the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an...
Depixus, Daiichi Sankyo Partner on MAGNA Technology
13/12/2023 - Daiichi will use MAGNA to explore the interactions of lead molecules with a number of undisclosed RNA targets.
Experic Installs New Capsule Filling Machine at New Jersey Facility
11/12/2023 - Provides enhanced protection of employees and the environment from highly potent pharmaceutical products.
Danaher Completes $5.7B Acquisition of Abcam
07/12/2023 - Abcam is a supplier of protein research tools for life sciences based in Cambridge, England.
Abzena, ProteoNic Partner to Offer Enhanced CHO Cell Line Platform
06/12/2023 - Vector technology designed to improve the production of high-yielding mammalian cell lines.
“La biotecnología está revolucionado el mundo”: cinco hitos que marcan el pulso del futuro de la ciencia, según Hugo Sigman
04/12/2023 - El fundador de uno de los gigantes farmacéuticos más importantes del mundo -Insud Pharma- habló con Infobae sobre su apuesta constante por la innovación y la...
PRISM BioLab, Lilly Enter PPI Discovery Collaboration
01/12/2023 - Aims to discover oral inhibitors of protein-protein interaction targets leveraging PRISM BioLab's PepMetics technology.
Ardena's New Aseptic Fill-Finish Plant Granted GMP License
01/12/2023 - Has capacity for large molecule biologics, including proteins, next to oligonucleotides (DNA, recombinant RNA, synthetic RNA, RNA vaccines) and peptides.
Charles River, GC4K Enter Gene Therapy Mfg. Pact
29/11/2023 - Will leverage Charles River’s plasmid platform, eXpDNA, and premier expertise in plasmid DNA production.